The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Androgen Receptor Regulates a Distinct Transcription Program in Androgen-Independent Prostate Cancer
Open accessAbstract
SUMMARY The evolution of prostate cancer from an androgen-dependent state (ADPCa) to one that is androgen-independent (AIPCa) marks its lethal progression. The androgen receptor (AR) is essential in both, though its function in AIPCa is poorly understood. We have defined the direct AR-dependent target genes in both AIPCa and ADPCa by generating AR-dependent gene expression profiles and AR cistromes. In contrast to ADPCa, AR selectively up-regulates M-phase cell cycle genes in AIPCa including UBE2C, a gene that inactivates the M-phase checkpoint. Selective epigenetic marks and collaborating transcription factor occupancy at UBE2C enhancers leads to increased AR recruitment and UBE2C over-expression in AIPCa cell lines and clinical cases. Silencing of UBE2C blocks AIPCa but not ADPCa growth. Thus the role of AR in AIPCa is not to direct the androgen-dependent gene expression program without androgen, but rather to execute a distinct program resulting in androgen-independent growth.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chromatin modifications and their function
Kouzarides, T. (2007) · Cell · doi:10.1016/j.cell.2007.02.005 · Cited by 10,883
In silico prediction of protein-protein interactions in human macrophages
Souiai, O., Guerfali, F., Ben Miled, S., Brun, C., & Benkahla, A. (2014) · BMC Research Notes · doi:10.1186/1756-0500-7-157 · Cited by 10,803
Exploration, normalization, and summaries of high density oligonucleotide array probe level data
Irizarry, R. A. (2003) · Biostatistics · doi:10.1093/biostatistics/4.2.249 · Cited by 10,603
Significance analysis of microarrays applied to the ionizing radiation response
Tusher, V. G., Tibshirani, R., & Chu, G. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.091062498 · Cited by 10,568
The nuclear receptor superfamily: the second decade
Mangelsdorf, D. J., Thummel, C., Beato, M., Herrlich, P., Schütz, G., Umesono, K., Blumberg, B., Kastner, P., Mark, M., Chambon, P., et al. (1995) · Cell · doi:10.1016/0092-8674(95)90199-x · Cited by 6,964
High-Resolution Profiling of Histone Methylations in the Human Genome
Barski, A., Cuddapah, S., Cui, K., Roh, T.-Y., Schones, D. E., Wang, Z., Wei, G., Chepelev, I., & Zhao, K. (2007) · Cell · doi:10.1016/j.cell.2007.05.009 · Cited by 6,845 · cited 1×
“It is also possible that other active histone marks present on gene enhancers (Barski et al., 2007) may play a role to facilitate transcription factor and coactivator recruitment.”
BackgroundDocetaxel plus Prednisone or Mitoxantrone plus Prednisone for Advanced Prostate Cancer
Tannock, I. F., de Wit, R., Berry, W. R., Horti, J., Pluzanska, A., Chi, K. N., Oudard, S., Théodore, C., James, N. D., Turesson, I., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040720 · Cited by 5,735
Histone demethylation mediated by the nuclear amine oxidase homolog LSD1
Shi, Y., Lan, F., Matson, C., Mulligan, P., Whetstine, J. R., Cole, P. A., Casero, R. A., & Shi, Y. (2004) · Cell · doi:10.1016/j.cell.2004.12.012 · Cited by 4,051
Petrylak, D. P., Tangen, C. M., Hussain, M. H. A., Lara, P. N., Jones, J. A., Taplin, M. E., Burch, P. A., Berry, D., Moinpour, C., Kohli, M., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa041318 · Cited by 3,665
Heintzman, N. D., Stuart, R. K., Hon, G., Fu, Y., Ching, C. W., Hawkins, R. D., Barrera, L. O., Van Calcar, S., Qu, C., Ching, K. A., et al. (2007) · Nature Genetics · doi:10.1038/ng1966 · Cited by 3,398 · cited 3×
“a Distinct Transcription Program in Androgen-Independent Prostate Cancer Qianben Wang,1,2,14,* Wei Li,3,14 Yong Zhang,4 Xin Yuan,5 Kexin Xu,1 Jindan Yu,6 Zhong Chen,2 Rameen Beroukhim,1,7 Hongyun Wang,5 Mathieu Lupien,1,13 Tao Wu,8 Meredith M. Regan,4 Clifford A. Meyer,4 Jason S. Carroll,9 Arjun…”
BackgroundInfluentialThe development of androgen-independent prostate cancer.
Feldman, B. J., & Feldman, D. (2001) · Nature reviews. Cancer · doi:10.1038/35094009 · Cited by 2,326
Molecular determinants of resistance to antiandrogen therapy
Chen, C. D., Welsbie, D. S., Tran, C., Baek, S. H., Chen, R., Vessella, R., Rosenfeld, M. G., & Sawyers, C. L. (2004) · Nature Medicine · doi:10.1038/nm972 · Cited by 2,278
Evolving gene/transcript definitions significantly alter the interpretation of GeneChip data
Dai, M. (2005) · Nucleic Acids Research · doi:10.1093/nar/gni179 · Cited by 1,797
Androgen Receptor in Prostate Cancer
Heinlein, C. A., & Chang, C. (2004) · Endocrine Reviews · doi:10.1210/er.2002-0032 · Cited by 1,780
Genomic Maps and Comparative Analysis of Histone Modifications in Human and Mouse
Bernstein, B. E., Kamal, M., Lindblad-Toh, K., Bekiranov, S., Bailey, D. K., Huebert, D. J., McMahon, S., Karlsson, E. K., Kulbokas, E. J., Gingeras, T. R., et al. (2005) · Cell · doi:10.1016/j.cell.2005.01.001 · Cited by 1,527
Carroll, J. S., Liu, X. S., Brodsky, A. S., Li, W., Meyer, C. A., Szary, A. J., Eeckhoute, J., Shao, W., Hestermann, E. V., Geistlinger, T. R., et al. (2005) · Cell · doi:10.1016/j.cell.2005.05.008 · Cited by 1,384
Self-citationMethylation of lysine 4 on histone H3: intricacy of writing and reading a single epigenetic mark
Ruthenburg, A. J., Allis, C. D., & Wysocka, J. (2007) · Molecular Cell · doi:10.1016/j.molcel.2006.12.014 · Cited by 1,147
Stanbrough, M., Bubley, G. J., Ross, K., Golub, T. R., Rubin, M. A., Penning, T. M., Febbo, P. G., & Balk, S. P. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4000 · Cited by 1,082
Self-citationScher, H. I., & Sawyers, C. L. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.4777 · Cited by 1,025
FoxA1 Translates Epigenetic Signatures into Enhancer-Driven Lineage-Specific Transcription
Lupien, M., Eeckhoute, J., Meyer, C. A., Wang, Q., Zhang, Y., Li, W., Carroll, J. S., Liu, X. S., & Brown, M. (2008) · Cell · doi:10.1016/j.cell.2008.01.018 · Cited by 983
Self-citationIntegrative molecular concept modeling of prostate cancer progression
Tomlins, S. A., Mehra, R., Rhodes, D. R., Cao, X., Wang, L., Dhanasekaran, S. M., Kalyana-Sundaram, S., Wei, J. T., Rubin, M. A., Pienta, K. J., et al. (2007) · Nature Genetics · doi:10.1038/ng1935 · Cited by 922
Self-citationCyclin a is required for the onset of DNA replication in mammalian fibroblasts
Girard, F., Strausfeld, U., Fernandez, A., & Lamb, N. J. C. (1991) · Cell · doi:10.1016/0092-8674(91)90293-8 · Cited by 880
Maximum androgen blockade in advanced prostate cancer: an overview of the randomised trials
(2000) · The Lancet · doi:10.1016/s0140-6736(00)02163-2 · Cited by 819
Varambally, S., Yu, J., Laxman, B., Rhodes, D. R., Mehra, R., Tomlins, S. A., Shah, R. B., Chandran, U., Monzon, F. A., Becich, M. J., et al. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.10.001 · Cited by 800
Self-citationQuantitative analysis of chromosome conformation capture assays (3C-qPCR)
Hagège, H., Klous, P., Braem, C., Splinter, E., Dekker, J., Cathala, G., de Laat, W., & Forné, T. (2007) · Nature Protocols · doi:10.1038/nprot.2007.243 · Cited by 720 · cited 2×
“3C-qPCR assays were performed essentially as described (Hagege et al., 2007) with minor modifications.”
MethodWang, Q., Li, W., Liu, X. S., Carroll, J. S., Jänne, O. A., Keeton, E. K., Chinnaiyan, A. M., Pienta, K. J., & Brown, M. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.05.041 · Cited by 687
Self-citationFormation of the Androgen Receptor Transcription Complex
Shang, Y., Myers, M., & Brown, M. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00471-9 · Cited by 672
Self-citationα-Methylacyl Coenzyme A Racemase as a Tissue Biomarker for Prostate Cancer
Rubin, M. A. (2002) · JAMA · doi:10.1001/jama.287.13.1662 · Cited by 644
Self-citationMechanisms of Androgen-Refractory Prostate Cancer
Debes, J. D., & Tindall, D. J. (2004) · New England Journal of Medicine · doi:10.1056/nejmp048178 · Cited by 558
Phosphorylation of serine 10 in histone H3, what for?
Prigent, C., & Dimitrov, S. (2003) · Journal of Cell Science · doi:10.1242/jcs.00735 · Cited by 491
Wang, Q., Carroll, J. S., & Brown, M. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.07.018 · Cited by 450
Self-citationModel-based analysis of tiling-arrays for ChIP-chip
Johnson, W. E., Li, W., Meyer, C. A., Gottardo, R., Carroll, J. S., Brown, M., & Liu, X. S. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0601180103 · Cited by 429
Self-citationCulig, Z., Hoffmann, J., Erdel, M., Eder, I. E., Hobisch, A., Hittmair, A., Bartsch, G., Utermann, G., Schneider, M. R., Parczyk, K., et al. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690684 · Cited by 409
LNCaP progression model of human prostate cancer: Androgen-independence and osseous metastasis
Thalmann, G. N., Sikes, R. A., Wu, T. T., Degeorges, A., Chang, S.-M., Ozen, M., Pathak, S., & Chung, L. W. K. (2000) · The Prostate · doi:10.1002/1097-0045(20000701)44:2<91::aid-pros1>3.0.co;2-l · Cited by 366
Self-citationUbiquitination by the anaphase-promoting complex drives spindle checkpoint inactivation
Reddy, S. K., Rape, M., Margansky, W. A., & Kirschner, M. W. (2007) · Nature · doi:10.1038/nature05734 · Cited by 356
Prostate-specific Antigen Expression Is Regulated by an Upstream Enhancer
Schuur, E. R., Henderson, G. A., Kmetec, L. A., Miller, J. D., Lamparski, H. G., & Henderson, D. R. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.12.7043 · Cited by 305
Xu, Y., Chen, S.-Y., Ross, K. N., & Balk, S. P. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4472 · Cited by 301
Self-citationResnitzky, D., Hengst, L., & Reed, S. I. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.8.4347 · Cited by 246
Yu, D., Sakamoto, G. T., & Henderson, D. (1999) · PubMed · Cited by 193
Cyclin A is required for the onset of DNA replication in mammalian fibroblasts
Girard, F., Strausfeld, U., Fernandez, A., & Lamb, N. J. C. (1992) · Trends in Cell Biology · doi:10.1016/0962-8924(92)90073-v · Cited by 189
SOX9 Is Expressed in Human Fetal Prostate Epithelium and Enhances Prostate Cancer Invasion
Wang, H., Leav, I., Ibaragi, S., Wegner, M., Hu, G.-F., Lu, M. L., Balk, S. P., & Yuan, X. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5915 · Cited by 163
Self-citationCoactivator AIB1 links estrogen receptor transcriptional activity and stability
Shao, W., Keeton, E. K., McDonnell, D. P., & Brown, M. A. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402997101 · Cited by 146
Self-citationHååg, P., Bektić, J., Bartsch, G. H., Klocker, H., & Eder, I. E. (2005) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2005.04.029 · Cited by 137
Wagner, K. W., Sapinoso, L. M., El-Rifai, W. M., Frierson, H. F., Butz, N., Mestan, J., Hofmann, F., Deveraux, Q. L., & Hampton, G. M. (2004) · Oncogene · doi:10.1038/sj.onc.1207861 · Cited by 131
A Coregulatory Role for the TRAP-Mediator Complex in Androgen Receptor-mediated Gene Expression
Wang, Q., Sharma, D., Ren, Y., & Fondell, J. D. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m206061200 · Cited by 127
Self-citationUbcH10 overexpression may represent a marker of anaplastic thyroid carcinomas
Pallante, P., Berlingieri, M. T., Troncone, G., Kruhøffer, M., Orntoft, T. F., Viglietto, G., Caleo, A., Migliaccio, I., Decaussin‐Petrucci, M., Santoro, M. M., et al. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602721 · Cited by 120
Lin, J., Raoof, D. A., Wang, Z., Lin, M., Thomas, D. G., Greenson, J. K., Giordano, T. J., Orringer, M. B., Chang, A. C., Beer, D. G., et al. (2006) · Neoplasia · doi:10.1593/neo.05832 · Cited by 63
Sun, Z. (1997) · Nucleic Acids Research · doi:10.1093/nar/25.16.3318 · Cited by 57
Comstock, C. E. S., & Knudsen, K. E. (2007) · Cell Cycle · doi:10.4161/cc.6.11.4353 · Cited by 34
Cited by
The mutational landscape of lethal castration-resistant prostate cancer
Grasso, C. S., Wu, Y.-M., Robinson, D. R., Cao, X., Dhanasekaran, S. M., Khan, A. P., Quist, M. J., Jing, X., Lonigro, R. J., Brenner, J. C., et al. (2012) · Nature · doi:10.1038/nature11125 · Cited by 2,517
Self-citationPioneer transcription factors: establishing competence for gene expression
Zaret, K. S., & Carroll, J. S. (2011) · Genes & Development · doi:10.1101/gad.176826.111 · Cited by 1,589
Self-citationMolecular genetics of prostate cancer: new prospects for old challenges
Shen, M. M., & Abate-Shen, C. (2010) · Genes & Development · doi:10.1101/gad.1965810 · Cited by 946
EZH2 Oncogenic Activity in Castration-Resistant Prostate Cancer Cells Is Polycomb-Independent
Xu, K., Wu, Z. J., Groner, A. C., He, H. H., Cai, C., Lis, R. T., Wu, X., Stack, E. C., Loda, M., Liu, T., et al. (2012) · Science · doi:10.1126/science.1227604 · Cited by 875
Self-citationYu, J., Yu, J., Mani, R.-S., Cao, Q., Brenner, C. J., Cao, X., Wang, X., Wu, L., Li, J., Hu, M., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.03.018 · Cited by 850
Self-citation
Metadata
- Authors
- Wang, Q., Li, W., Zhang, Y., Yuan, X., Xu, K., Yu, J., Chen, Z., Beroukhim, R., Wang, H., Lupien, M., Wu, T., Regan, M. M., Meyer, C. A., Carroll, J. S., Manrai, A. K., Jänne, O. A., Balk, S. P., Mehra, R., Han, B., Chinnaiyan, A. M., Rubin, M. A., True, L., Fiorentino, M., Fiore, C., Loda, M., Kantoff, P. W., Liu, X. S., & Brown, M.
- Venue
- Cell
- Publisher
- Elsevier BV
- Published
- 2009-07
- Volume
- 138
- Issue
- 2
- Pages
- 245-256
- ISSN
- 0092-8674 (ISSN-L)
- OpenAlex
- W2089518544
- Cited by
- 902
- References
- 50
- FWCI
- 54.12
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.